BMO Capital Downgrades Valeant Pharmaceuticals (VRX) to Market Perform; Cannot Defend the Specialty Pharmacy Structure

Go back to BMO Capital Downgrades Valeant Pharmaceuticals (VRX) to Market Perform; Cannot Defend the Specialty Pharmacy Structure

Pershing Square Holdings, Ltd. Increases Position In Valeant Pharmaceuticals International

October 21, 2015 7:35 PM EDT

AMSTERDAM--(BUSINESS WIRE)-- Pershing Square Holdings, Ltd. (ticker: PSH:NA) confirms media reports that Pershing Square Capital Management purchased, on behalf of the funds it manages, in excess of 2 million additional shares of Valeant Pharmaceuticals International, Inc. (ticker: NYSE: VRX) on 21 October 2015.

About Pershing Square... More

Sutts, Strosberg LLP Announces Investigation of Valeant Pharmaceuticals International Inc.

October 21, 2015 2:31 PM EDT

WINDSOR, Ontario--(BUSINESS WIRE)-- Valeant Pharmaceuticals International Inc. (NYSE: VRX; TSX: VRX), is being investigated by Sutts, Strosberg LLP, a law firm that represents investors in securities class actions.

The firm is investigating the company in the wake of a report by Citron... More

Valeant Pharmaceuticals Responds To Erroneous Report

October 21, 2015 1:39 PM EDT

LAVAL, Quebec, Oct. 21, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today responded to recent accusations made regarding its financial reporting and operations.

Philidor Rx Services is a pharmacy licensed in Pennsylvania and also provides back-end services, including call center, claims adjudication, IT and logistics support, as well as compliance/HIPPA regulation guidance, to other pharmacies, including R&O Pharmacy.  This includes a common call center phone number serviced by Philidor for the Philidor network pharmacies.  All... More